SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's Laboratories informs about allotment under ESOP

07 Oct 2022 Evaluate
Dr Reddy's Laboratories has informed that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company has approved the allotment of 30,785 equity shares of Rs 5 each of the Company, fully paid up, on October 7, 2022, to employee(s) pursuant to exercise of their Stock Options, as per the following details: 30,785 equity shares of Rs 5 each underlying 30,785 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007. Further, it enclosed the details as required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Labs. Share Price

1403.75 53.75 (3.98%)
29-Jun-2026 11:00 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1888.70
Dr. Reddys Labs. 1403.75
Cipla 1479.00
Zydus Lifesciences 1121.30
Lupin 2398.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: